http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105126113-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
filingDate 2015-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105126113-B
titleOfInvention A kind of preparation method and applications of hollow mesoporous copper sulfide/Artesunate nanoparticle of Surface-modified by Transferrin
abstract The present invention relates to the preparation method and applications of hollow mesoporous copper sulfide/Artesunate nanoparticle of Surface-modified by Transferrin,It can effectively solve that there is targeting simultaneously,Photo-thermal therapy,Photodynamic therapy,Photoacoustic imaging,Drug therapy and generation DMR effects,Realize the integrated problem of diagnosing and treating,Method is,First synthesize hollow mesoporous nano copper sulfate particle,In the copper sulfide internal load drug Artesunate of hollow meso-hole structure,Upper transferrins is modified by Electrostatic Absorption again,Hollow mesoporous copper sulfide/Artesunate nanoparticle of Surface-modified by Transferrin is made,Synthesis technology of the present invention is simple,After being injected by cancer week,Anticancer drug is transmitted to cancer location,Further increase therapeutic effect,Reduce the toxic side effect of normal tissue and cell,With infrared photo-thermal therapy effect,Photodynamic therapy can also be carried out,Photoacoustic imaging,Realize photo-thermal therapy-photodynamic therapy-chemotherapy-diagnosing tumor complex treatment integration,It is the big innovation in tumor.
priorityDate 2015-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID30255
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00775
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426397992
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00764
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24538
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14831
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24825
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35034
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID613079
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100136560
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23916
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID35608
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27425
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81071
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22297
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70059
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280705
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ02942
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID22041
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19134
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ26643
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447669256
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP09571
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24664
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00761
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP02787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID32821
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ29443
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP12346
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA5A6I6
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9821433
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID35608
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522604
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19799
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447827115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491185
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51588
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449682174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100009267
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ921I1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID36800
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35051
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24654
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ59149
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97399
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100034176
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7018
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35050

Total number of triples: 73.